Senators Introduce Bill To Extend Patent Rights For Biodefense Drugs

Law360, New York (May 6, 2005, 12:00 AM EDT) -- Senators Joseph Lieberman and Orrin Hatch have introduced the controversial BioShield II legislation, which would extend data exclusivity and patents for “a very large number of medicines” if drug companies develop biodefense countermeasures.

The legislation, introduced last week, aims to spur development of products based on government research by restoring patents terms held by the National Institutes of Health so companies will be more likely to license NIH-funded technologies and further develop them.

Under the patent restoration measure, companies would get an approximate 17-year patent if...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.